Showing results (311-320 of 753) with videos related to
Sort By:
Pageof 76
Journal of Neuro-Oncology|July 2, 2011
The roles of viruses in brain tumor initiation and oncomodulationAlexander Kofman, Lucasz Marcinkiewicz, Evan Dupart, et al.Journal of Neuro-Oncology|December 2, 2008
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant gliomaAndrew D Norden, Jan Drappatz, Alona Muzikansky, et al.Neuro-Oncology|January 31, 2006
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomasGaurav D Shah, Santosh Kesari, Ronghui Xu, et al.Neuro-Oncology Practice|October 25, 2021
Emergency department visits and inpatient hospitalizations among older patients with brain metastases: a dual population- and institution-level analysisNayan Lamba, Paul J Catalano, Colleen Whitehouse, et al.Leukemia & Lymphoma|June 5, 2012
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphomaLakshmi Nayak, Lauren E Abrey, Jan Drappatz, et al.Investigational New Drugs|November 13, 2014
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastomaDavid Schiff, Santosh Kesari, John de Groot, et al.Cureus|December 18, 2015
Improving Brain Tumor Research in Resource-Limited Countries: A Review of the Literature Focusing on West AfricaSaidu I Ngulde, Francis Fezeu, Arjun Ramesh, et al.Journal of Neuropathology and Experimental Neurology|May 1, 2009
Dephosphorylation of beta-arrestin 1 in glioblastomasJames W Mandell, George Glass, Erwin P Gianchandani, et al.Neuro-Oncology|December 18, 2019
Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effortAli S Haider, Martin van den Bent, Patrick Y Wen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomasHoward A Fine, Patrick Y Wen, Elizabeth A Maher, et al.Pageof 76